# ENDO Pharmaceuticals Solutions, Inc., Cranbury, NJ – FDA Inspections

Source: https://www.keypedia.com/companies/endo-pharmaceuticals-solutions-inc/73c5da1a-04ad-4b56-9fae-f0a1371df51f

> Inspection records and compliance data for ENDO Pharmaceuticals Solutions, Inc. in Cranbury, New Jersey. 5 FDA inspections on record, 2 Form 483s, last inspected January 17, 2025.

---

## Details

- Name: ENDO Pharmaceuticals Solutions, Inc.
- FEI Number: 2243842
- Business Operations: PACK
- Address Line 1: 8 Clarke Dr
- City: Cranbury
- State: New Jersey
- Zip Code: 08512
- Country Name: United States
- Address: 8 Clarke Dr, Cranbury, New Jersey 08512, United States
- Country: United States

## Related Documents

- [483 - ENDO Pharmaceuticals Solutions, Inc. - 2025-01-17](https://www.keypedia.com/records/483/endo-pharmaceuticals-solutions-inc/6df7ce6f-8cff-42c6-bf2b-924f87310dd5) — source: FDA, date: January 17, 2025
- [FDA Inspection 1258791 - ENDO Pharmaceuticals Solutions, Inc. - 2025-01-17](https://www.keypedia.com/records/fda_inspections/endo-pharmaceuticals-solutions-inc/f4aff197-d988-42c2-8bf2-f915a6ab5b0c) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 17, 2025
- [483 - ENDO Pharmaceuticals Solutions, Inc. - 2018-10-23](https://www.keypedia.com/records/483/endo-pharmaceuticals-solutions-inc/0470733a-57bb-4e4b-9ba6-c481522df941) — source: FDA, date: October 23, 2018
- [FDA Inspection 1069481 - ENDO Pharmaceuticals Solutions, Inc. - 2018-10-23](https://www.keypedia.com/records/fda_inspections/endo-pharmaceuticals-solutions-inc/b2423310-a401-4fe5-8f08-d7c052e1fa13) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 23, 2018
- FDA Inspection 868436 - ENDO Pharmaceuticals Solutions, Inc. - 2014-03-04 — classification: No Action Indicated (NAI), source: FDA, date: March 4, 2014
- FDA Inspection 758818 - ENDO Pharmaceuticals Solutions, Inc. - 2011-12-21 — classification: No Action Indicated (NAI), source: FDA, date: December 21, 2011
- FDA Inspection 694965 - ENDO Pharmaceuticals Solutions, Inc. - 2010-11-09 — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 9, 2010

## Related Companies

- [Kaysersberg Pharmaceuticals SAS](https://www.keypedia.com/companies/kaysersberg-pharmaceuticals-sas/4f0bba88-dadd-49db-8e17-08165e705377)
- [Steriscience Specialties Private Limited](https://www.keypedia.com/companies/steriscience-specialties-private-limited/f2814c8b-daff-42a4-abe2-59947a5bda3d)
- [Baxter Pharmaceuticals India Pvt Ltd](https://www.keypedia.com/companies/baxter-pharmaceuticals-india-pvt-ltd/dc51d849-2ff2-4ad0-bb54-cb013fd2e24d)
- [Mylan Laboratories Limited](https://www.keypedia.com/companies/mylan-laboratories-limited/977203cc-5cbe-49ea-9b42-0b797ade4b5e)
- [Steriscience SP. Z O.O.](https://www.keypedia.com/companies/steriscience-sp-z-oo/a2c32aee-8f5f-4bd3-8cc9-9fdcf970ebf4)
- [Ningbo Shuangcheng Pharmaceutical Co., Ltd](https://www.keypedia.com/companies/ningbo-shuangcheng-pharmaceutical-co-ltd/942c1651-ee36-4163-9687-ca694ddc24d2)
- [Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Huanghe Road Site)](https://www.keypedia.com/companies/jiangsu-hengrui-pharmaceuticals-co-ltd-huanghe-road-site/02eeb237-fdd8-40a0-b45c-d4d88f49eb6c)
- [Lyocontract GmbH](https://www.keypedia.com/companies/lyocontract-gmbh/0c56698a-6a88-4c94-9de9-6e9f5172cf27)
- [Baxter SA](https://www.keypedia.com/companies/baxter-sa/4cc540bc-58e1-460a-be6e-c6c8c7d2ee47)
- [Baxter Healthcare Pty Ltd](https://www.keypedia.com/companies/baxter-healthcare-pty-ltd/a37e00b9-5cbd-4f45-922b-0f352f015507)

## Related Officers

- [investigator](https://www.keypedia.com/people/maria-estrella/36cf1d7d-41af-4f40-9de4-174a82a31a56)
- [Adetutu M. Gidado](https://www.keypedia.com/people/adetutu-m-gidado/6c4e8cf3-0eea-4903-9ca5-e8e2d683621d)
- [Amatul H. Marium](https://www.keypedia.com/people/amatul-h-marium/5db400ce-ffde-4310-82f8-766fd2458a4d)
- [Ankur C. Patel](https://www.keypedia.com/people/ankur-c-patel/602c7d14-2c48-4929-a07b-6e4c235d7f13)